The Barcelona Clinic Liver Cancer (BCLC) staging system classifies HCC according to patient characteristics (performance status, PS) and prognosis (Child-Pugh, alpha-fetoprotein [AFP] level, MELD, ALBI score, tumour size and liver function) (8). This evidence concerns the gene AFP and liver cancer.